GlaxoSmithKline PLC ADR(GSK)
34.87
Change: 0 (0)
As of Tue 12/20/2022 03:19 PM% Of Value
Growth
Value Per Share
:
:
:
656.70
-2.37
5.8200 (as of 19/12/2022)
Fundamentals Data
| Open | 35.02 | Dividend | 2455 |
| Close Price | 34.87 | DivYield | 5.06 % |
| High | 35.14 | Growth | -1.2 B |
| Low | 34.73 | Growth% | -2.37 |
| P/e | 22.621 | Volume | 3.1 M |
| P/b | 0.02 | Market Capital | 187.3 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 33.23 (as of 20/12/2022) | 50 Days Moving Average Percentage | 6.7465618860511 (as of 20/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2014 | Year2 / 2015 | Year3 / 2016 | Year4 / 2017 | Current Year / 2018 |
| Revenue | 23.0 B | 23.9 B | 27.8 B | 30.1 B | 30.8 B |
| Cap Spending | -1.1 B | -1.3 B | -1.4 B | -1.2 B | -1.1 B |
| Operating Expenses | 12.0 B | 4.7 B | 16.0 B | 15.7 B | 15.0 B |
| Operating Cash Flow | 3.5 B | 10.3 B | 2.5 B | 4.0 B | 5.4 B |
| Free Cash Flow | 5.1 B | 3.3 B | 6.6 B | 6.9 B | 8.5 B |
| Free Cash Flow Per Share | 0.959 | 0.62 | 1.241 | 1.302 | 1.593 |
| Total liabilities | 18.7 B | 16.6 B | 18.7 B | 17.0 B | 26.0 B |
| Total cash | 4.3 B | 5.8 B | 4.8 B | 3.8 B | 3.8 B |
| ROE% | 0.49 | 1.796 | 0.292 | 2.902 | 1.688 |
| Outstanding Shares | 5.3 B | 5.3 B | 5.3 B | 5.3 B | 5.3 B |
| P/E | 29.845 | 8.81 | 100.733 | 46.877 | 22.621 |
| P/S | 3.575 | 3.101 | 3.294 | 2.379 | 2.659 |
| Revenue USD | 35.5 B | 34.6 B | 34.4 B | 42.0 B | 41.0 B |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|